• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿奇霉素诱导支气管上皮细胞抗病毒反应。

Azithromycin induces anti-viral responses in bronchial epithelial cells.

机构信息

Dept of Respiratory Medicine National Heart & Lung Institute St Mary's Campus, Imperial College London, MRC and Asthma UK Centre for Allergic Mechanisms of Asthma, W2 1PG, London, UK.

出版信息

Eur Respir J. 2010 Sep;36(3):646-54. doi: 10.1183/09031936.00095809. Epub 2010 Feb 11.

DOI:10.1183/09031936.00095809
PMID:20150207
Abstract

The majority of asthma exacerbations are caused by rhinovirus. Currently the treatment of asthma exacerbations is inadequate. Previous evidence suggests that macrolide antibiotics have anti-inflammatory and antiviral effects; however, the mechanism is unknown. We investigated the anti-rhinoviral potential of macrolides through the induction of antiviral gene mRNA and protein. Primary human bronchial epithelial cells were pre-treated with the macrolides azithromycin, erythromycin and telithromycin, and infected with minor-group rhinovirus 1B and major-group rhinovirus 16. The mRNA expression of the antiviral genes, type I interferon-β and type III interferon-λ1, interferon-λ2/3, and interferon-stimulated genes (retinoic acid inducible gene I, melanoma differentiation associated gene 5, oligoadenylate synthase, MxA and viperin) and pro-inflammatory cytokines (interleukin (IL)-6 and IL-8), and rhinovirus replication and release were measured. Azithromycin, but not erythromycin or telithromycin, significantly increased rhinovirus 1B- and rhinovirus 16-induced interferons and interferon-stimulated gene mRNA expression and protein production. Furthermore, azithromycin significantly reduced rhinovirus replication and release. Rhinovirus induced IL-6 and IL-8 protein and mRNA expression were not significantly reduced by azithromycin pre-treatment. In conclusion, the results demonstrate that azithromycin has anti-rhinoviral activity in bronchial epithelial cells and, during rhinovirus infection, increases the production of interferon-stimulated genes.

摘要

大多数哮喘恶化是由鼻病毒引起的。目前,哮喘恶化的治疗还不够充分。先前的证据表明,大环内酯类抗生素具有抗炎和抗病毒作用;然而,其机制尚不清楚。我们通过诱导抗病毒基因 mRNA 和蛋白来研究大环内酯类药物的抗鼻病毒潜力。原代人支气管上皮细胞用大环内酯类药物阿奇霉素、红霉素和泰利霉素预处理,然后用小核糖核酸病毒 1B 和大核糖核酸病毒 16 感染。测量抗病毒基因(I 型干扰素-β和 III 型干扰素-λ1、干扰素-λ2/3、干扰素刺激基因(维甲酸诱导基因 I、黑色素瘤分化相关基因 5、寡聚腺苷酸合成酶、MxA 和 viperin)和促炎细胞因子(白细胞介素(IL)-6 和 IL-8)的 mRNA 表达以及鼻病毒复制和释放。阿奇霉素,但不是红霉素或泰利霉素,显著增加了鼻病毒 1B 和鼻病毒 16 诱导的干扰素和干扰素刺激基因的 mRNA 表达和蛋白产生。此外,阿奇霉素显著降低了鼻病毒的复制和释放。鼻病毒诱导的白细胞介素(IL)-6 和 IL-8 蛋白和 mRNA 表达经阿奇霉素预处理后无明显降低。总之,结果表明阿奇霉素对支气管上皮细胞具有抗鼻病毒活性,并且在鼻病毒感染期间增加干扰素刺激基因的产生。

相似文献

1
Azithromycin induces anti-viral responses in bronchial epithelial cells.阿奇霉素诱导支气管上皮细胞抗病毒反应。
Eur Respir J. 2010 Sep;36(3):646-54. doi: 10.1183/09031936.00095809. Epub 2010 Feb 11.
2
Diversity in the bronchial epithelial cell response to infection with different rhinovirus strains.支气管上皮细胞对不同鼻病毒株感染的反应存在差异。
Respirology. 2009 Mar;14(2):180-6. doi: 10.1111/j.1440-1843.2009.01480.x. Epub 2009 Feb 4.
3
Azithromycin induces anti-viral effects in cultured bronchial epithelial cells from COPD patients.阿奇霉素可诱导 COPD 患者培养的支气管上皮细胞产生抗病毒作用。
Sci Rep. 2016 Jun 28;6:28698. doi: 10.1038/srep28698.
4
Azithromycin augments rhinovirus-induced IFNβ via cytosolic MDA5 in experimental models of asthma exacerbation.在哮喘加重的实验模型中,阿奇霉素通过胞质中的黑色素瘤分化相关基因5(MDA5)增强鼻病毒诱导的β干扰素。
Oncotarget. 2017 May 9;8(19):31601-31611. doi: 10.18632/oncotarget.16364.
5
Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus.哮喘支气管上皮细胞对鼻病毒感染的固有免疫反应存在缺陷。
J Exp Med. 2005 Mar 21;201(6):937-47. doi: 10.1084/jem.20041901.
6
Impaired type I and type III interferon induction and rhinovirus control in human cystic fibrosis airway epithelial cells.囊性纤维化气道上皮细胞中 I 型和 III 型干扰素诱导和鼻病毒控制受损。
Thorax. 2012 Jun;67(6):517-25. doi: 10.1136/thoraxjnl-2011-200405. Epub 2012 Jan 2.
7
Identification of novel macrolides with antibacterial, anti-inflammatory and type I and III IFN-augmenting activity in airway epithelium.在气道上皮细胞中鉴定具有抗菌、抗炎以及增强I型和III型干扰素活性的新型大环内酯类化合物。
J Antimicrob Chemother. 2016 Oct;71(10):2767-81. doi: 10.1093/jac/dkw222. Epub 2016 Jul 25.
8
Novel antiviral properties of azithromycin in cystic fibrosis airway epithelial cells.阿奇霉素在囊性纤维化气道上皮细胞中的新型抗病毒特性。
Eur Respir J. 2015 Feb;45(2):428-39. doi: 10.1183/09031936.00102014. Epub 2014 Oct 30.
9
Exogenous IFN-β has antiviral and anti-inflammatory properties in primary bronchial epithelial cells from asthmatic subjects exposed to rhinovirus.外源性 IFN-β 在暴露于鼻病毒的哮喘患者的原代支气管上皮细胞中具有抗病毒和抗炎特性。
J Allergy Clin Immunol. 2011 May;127(5):1148-54.e9. doi: 10.1016/j.jaci.2011.01.023. Epub 2011 Feb 16.
10
Protein kinase R, IkappaB kinase-beta and NF-kappaB are required for human rhinovirus induced pro-inflammatory cytokine production in bronchial epithelial cells.蛋白激酶R、IκB激酶β和核因子κB是人类鼻病毒诱导支气管上皮细胞产生促炎细胞因子所必需的。
Mol Immunol. 2007 Mar;44(7):1587-97. doi: 10.1016/j.molimm.2006.08.014. Epub 2006 Sep 20.

引用本文的文献

1
A bioinformatic analysis to systematically unveil shared pathways and molecular mechanisms underlying monkeypox and its predominant neurological manifestations.一项生物信息学分析,旨在系统揭示猴痘及其主要神经学表现背后的共同途径和分子机制。
Front Cell Infect Microbiol. 2025 Jul 2;15:1506687. doi: 10.3389/fcimb.2025.1506687. eCollection 2025.
2
Azithromycin mitigates human rhinovirus impact on barrier integrity and function in non-diseased airway epithelium.阿奇霉素减轻人鼻病毒对非病变气道上皮屏障完整性和功能的影响。
Front Cell Dev Biol. 2025 Jun 26;13:1532656. doi: 10.3389/fcell.2025.1532656. eCollection 2025.
3
Effects of azithromycin treatment on bronchial epithelial antiviral immunity in asthma phenotypes.
阿奇霉素治疗对哮喘不同表型支气管上皮抗病毒免疫的影响。
Front Allergy. 2025 Jun 17;6:1605109. doi: 10.3389/falgy.2025.1605109. eCollection 2025.
4
Monkeypox virus spreads from cell-to-cell and leads to neuronal death in human neural organoids.猴痘病毒在细胞间传播,并导致人类神经类器官中的神经元死亡。
Nat Commun. 2025 Jun 30;16(1):5376. doi: 10.1038/s41467-025-61134-0.
5
Challenges and Opportunities for Post-COVID Pulmonary Disease: A Focused Review of Immunomodulation.新冠后肺部疾病的挑战与机遇:免疫调节的重点综述
Int J Mol Sci. 2025 Apr 18;26(8):3850. doi: 10.3390/ijms26083850.
6
Recent advances in the prevention and treatment of respiratory syncytial virus disease.呼吸道合胞病毒疾病预防与治疗的最新进展
J Gen Virol. 2025 Apr;106(4). doi: 10.1099/jgv.0.002095.
7
Aging shapes infection profiles of influenza A virus and SARS-CoV-2 in human precision-cut lung slices.衰老塑造了甲型流感病毒和新冠病毒在人精密切割肺切片中的感染特征。
Respir Res. 2025 Mar 24;26(1):112. doi: 10.1186/s12931-025-03190-0.
8
A bioinformatics approach combined with experimental validation analyzes the efficacy of azithromycin in treating SARS-CoV-2 infection in patients with IPF and COPD These authors contributed equally: Yining Xie, Guangshu Chen, and Weiling Wu.一种结合实验验证的生物信息学方法分析了阿奇霉素治疗特发性肺纤维化(IPF)和慢性阻塞性肺疾病(COPD)患者的新型冠状病毒肺炎(SARS-CoV-2)感染的疗效。 这些作者贡献相同:谢伊宁、陈广舒和吴维玲。
Sci Rep. 2025 Mar 23;15(1):10009. doi: 10.1038/s41598-025-94801-9.
9
Repositioning of Antibiotics in the Treatment of Viral Infections.抗生素在病毒感染治疗中的再定位。
Curr Microbiol. 2024 Oct 26;81(12):427. doi: 10.1007/s00284-024-03948-7.
10
Efficacy of Ivermectin, Chloroquine/Hydroxychloroquine, and Azithromycin in Managing COVID-19: A Systematic Review of Phase III Clinical Trials.伊维菌素、氯喹/羟氯喹及阿奇霉素治疗新冠肺炎的疗效:III期临床试验的系统评价
Biomedicines. 2024 Sep 27;12(10):2206. doi: 10.3390/biomedicines12102206.